Earnings call transcript: Minerva Foods Q1 2026 results show mixed performance

Minerva Foods delivered mixed Q1 2026 results: EPS of $0.26 missed the $0.3775 forecast by 31.1%, but revenue beat expectations at $13.41B versus $13.23B and shares rose 3.27% to $4.10. Management said 2026 margins should be lower than 2025 due to higher cattle prices, but expects top-line growth, stable working capital for the year, and CapEx below Q1 levels. The company also highlighted continued deleveraging, liability management, and sustainability initiatives, with net leverage steady at 2.7x and cash near BRL 10.9B.

Analysis

The market is starting to price Minerva less like a cyclical processor and more like a quasi-asset-light arbitrage platform. The key second-order effect is not the quarter’s headline miss, but that tighter gross margins are being partially neutralized by fixed-cost dilution from a larger operating base, which should make earnings less volatile than the raw cattle cycle would suggest. That matters because the company is effectively using geographic optionality to monetize dislocations in China, the U.S., and domestic markets as quota and tariff regimes re-route flows.

The bigger earnings-quality signal is balance-sheet behavior: management is intentionally converting excess liquidity into gross leverage reduction while still preserving a minimum cash buffer. In a high-rate environment, that is economically rational because every incremental BRL of cash held is a low-return insurance policy versus debt carry, especially with near-term maturities and FX exposure. The funding mix also implies a lower refinancing-risk premium over the next 2-3 quarters if credit markets remain open.

The main risk is that the current profitability bridge relies on continued price dispersion across regions; if Chinese quota-related distortions normalize faster than expected or Brazil’s internal market absorbs excess supply poorly, margin leverage can compress before cost dilution catches up. Working capital is also likely to remain noisy into Q2/Q3 as higher cattle input costs lag through the cycle, so the equity could stay range-bound until cash conversion proves out. The stock’s cheap multiple looks real, but the rerating requires evidence that EBITDA can hold while free cash flow remains positive through the seasonal burn period.

Consensus appears to be underestimating how much the integration changed the operating profile: the acquired assets are not just adding volume, they are expanding routing flexibility and reducing reliance on any single destination. That makes the company more resilient than a simple beef exporter, and it also raises the odds that domestic-market weakness in one country is offset by arbitrage elsewhere. The move may be underdone if investors focus only on near-term margin compression and miss the structural decline in financing stress plus the improved ability to capture spread opportunities across the region.

Key Decisions for Investors

• Long BEEF3 / Minerva equity into the next 1-2 quarters as a value-with-catalyst trade: downside is limited by low multiple and deleveraging, upside comes from any confirmation that EBITDA remains sticky while working capital normalizes.
• Pair trade: long BEEF3 vs short a more domestically exposed regional protein or agribusiness name with weaker geographic diversification over the next 3-6 months; Minerva should outperform if trade flows stay fragmented and credit spreads remain favorable.
• Buy short-dated downside protection on BEEF3 into Q2 if liquidity/working-capital volatility is the market’s main concern: use puts to hedge against a temporary cash burn spike while keeping upside exposure to rerating.
• If available in the broader market, favor Latin American exporters with FX and routing optionality over pure-play domestic processors for the next 6-12 months; Minerva is the cleaner expression of that theme.
• Do not chase after a one-day rally; wait for a pullback or for confirmation that Q2 pricing still supports the China/U.S. arbitrage before adding. Best entry is on weakness if the stock revisits the lower end of its recent range.